Lilian Jallow-Walther

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Evaluation of safety and efficacy of multiple intravenous and intraosseous doses of foetal liver-derived mesenchymal stem cells in children with severe osteogenesis imperfecta : the BOOST2B clinical trial protocol.

Evaluation of safety and efficacy of multiple intravenous and intraosseous doses of foetal liver-derived mesenchymal stem cells in children with severe osteogenesis imperfecta : the BOOST2B clinical trial protocol.

Journal: Bone & joint open

Published: March 23, 2025

An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocol.

An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocol.

Journal: BMJ open

Published: June 04, 2024

Successful transport across continents of GMP-manufactured and cryopreserved culture-expanded human fetal liver-derived mesenchymal stem cells for use in a clinical trial.

Successful transport across continents of GMP-manufactured and cryopreserved culture-expanded human fetal liver-derived mesenchymal stem cells for use in a clinical trial.

Journal: Regenerative therapy

Published: March 11, 2024

Transcriptomic and proteomic profiles of fetal versus adult mesenchymal stromal cells and mesenchymal stromal cell-derived extracellular vesicles.

Transcriptomic and proteomic profiles of fetal versus adult mesenchymal stromal cells and mesenchymal stromal cell-derived extracellular vesicles.

Journal: Stem cell research & therapy

Published: November 08, 2023

Maternal and fetal safety outcomes after in utero stem cell injection: A systematic review.

Maternal and fetal safety outcomes after in utero stem cell injection: A systematic review.

Journal: Prenatal diagnosis

Published: August 20, 2023

Mesenchymal Stem Cell Therapy for Osteogenesis Imperfecta.

Mesenchymal Stem Cell Therapy for Osteogenesis Imperfecta.

Journal: Clinical obstetrics and gynecology

Published: September 12, 2021

Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma.

Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma.

Journal: Cell reports. Medicine

Published: March 30, 2021

Stem Cell Therapy as a Treatment for Osteogenesis Imperfecta.

Stem Cell Therapy as a Treatment for Osteogenesis Imperfecta.

Journal: Current osteoporosis reports

Published: July 26, 2020

Prenatal stem cell therapy for inherited diseases: Past, present, and future treatment strategies.

Prenatal stem cell therapy for inherited diseases: Past, present, and future treatment strategies.

Journal: Stem cells translational medicine

Published: April 08, 2019

Fetal Mesenchymal Stromal Cells: an Opportunity for Prenatal Cellular Therapy.

Fetal Mesenchymal Stromal Cells: an Opportunity for Prenatal Cellular Therapy.

Journal: Current stem cell reports

Published: March 31, 2018

A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder.

A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder.

Journal: Molecular psychiatry

Published: May 20, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026